Adimab (United States)

Adimab (United States)

Open Access statistics for Adimab (United States), United States, covering academic research published from 2010 to 2023.

Open Access statistics for Adimab (United States), United States, covering academic research published from 2010 to 2023. Read More.


Open Access Percentage

88%


Total
Publications

115


Total Open
Publications

101


Total
Citations

6.4K


Open Access
Percentage

88%


Total
Publications

115


Total Open
Publications

101


Total
Citations

6.4K

Website

download

Breakdown

10% 58% 20% 12%

Publisher Open

10%

Both

58%

Other Platform Open

20%

Closed

12%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
20102011201220132014201520162017201820192020202120222023

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0246810121416Total Publications
20102011201220132014201520162017201820192020202120222023

Open

Closed

Publisher Open

32%OA Journal

OA Journal 32%

25

Hybrid 32%

25

No Guarantees 36%

28

Other Platform Open

Domain 89%

80

Preprint 24%

22

Institution 18%

16

Other Internet 12%

11

Public 1%

1

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
80
Europe PMC
Domain
39
bioRxiv
Preprint
17
DOI
Other Internet
6
U.S. Department of Energy Office of Scientific and Technical Information - OSTI OAI
Institution
4
medRxiv
Preprint
3
Massachusetts Institute of Technology - DSpace@MIT
Institution
3
Figshare
Public
3
University of North Carolina at Chapel Hill - Carolina Digital Repository
Institution
2
Umeå University - DiVA at Umeå University
Institution
2
1 / 3

Data updated 8 December 2024

Share

Share

Share